Itemized Accounted And Other Active Ingredients

  Address - Hungary

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 106667744

  Document Type - Tender Notices

Description - Description: Purchase of the active ingredients of expired patent protection, as well as lapatinib and Durvvalumab active ingredients, is subject to the conclusion of the framework agreement, the Kbt. In the framework of an open procedure referred to in Article 105 (1) (a), with the possibility of further extending the active period of the framework agreement. The subject of this procurement procedure (in part): Part 1: Rituximab IV. (Oeno: 06058): Total amount: 24 000 000 mg (basic amount: 18,000 000 mg + 6 000 000 mg option) Part 2: Ustkinumab (Oeno: 06056): Total frame amount: 2 948 400 mg (basic amount: 2 211 300 mg + 737 100 mg) (Oeno: 06061): Total frame quantity: 9,030 000 mg (basic a

Gt Ref Id - 106667744

Deadline - May 12, 2025